---
schema_version: "secwatch.filing_event.v1"
accession: "0000879169-26-000046"
form_type: "8-K"
ticker: "INCY"
cik: "0000879169"
company_name: "INCYTE CORP"
filed_at: "2026-06-22T11:00:40+00:00"
generated_at: "2026-06-22T11:05:33.109837+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Incyte settles CMS dispute over Opzelura Medicaid rebates; records $246M benefit

## Summary
- CMS will not apply line extension regulation to Opzelura as if it were a line extension of Jakafi; Incyte withdraws lawsuit.
- One-time non-cash benefit of ~$246M in Q2 2026 from reversal of previously accrued liabilities through March 31, 2026.
- No future accruals for potential line extension regulations; expects improvement to Opzelura's gross-to-net.
- Company plans to update financial guidance on next scheduled earnings release.

## SEC filing metadata
- accession: 0000879169-26-000046
- form_type: 8-K
- ticker: INCY
- cik: 0000879169
- company_name: INCYTE CORP
- filed_at: 2026-06-22T11:00:40+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/879169/000087916926000046/0000879169-26-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/879169/000087916926000046/incy-20260622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000879169-26-000046
- JSON: https://secwatch.observer/filing/0000879169-26-000046.json
- Plain text: https://secwatch.observer/filing/0000879169-26-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.